Biotech · Private company
AmMax Bio, Inc.
Track this companyFree. Adds AmMax Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- AMB-05XPhase 2 · Pigmented Villonodular SynovitisClinicalTrials.gov · fetched Nov 12, 2026
- AMB-05XPhase 2 · Tenosynovial Giant Cell TumorClinicalTrials.gov · fetched Nov 12, 2026
- AMG820 and pembrolizumabPhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- AMG 820Phase 1 · Advanced MalignancyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCTPHASE2 · COMPLETED · started Jan 26, 2023ClinicalTrials.gov NCT05349643 · fetched Nov 12, 2026
- An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the KneePHASE2 · COMPLETED · started May 25, 2021ClinicalTrials.gov NCT04731675 · fetched Nov 12, 2026
- Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor CancerPHASE1_PHASE2 · COMPLETED · started Apr 14, 2016ClinicalTrials.gov NCT02713529 · fetched Nov 12, 2026
- A Study of AMG 820 in Subjects With Advanced Solid TumorsPHASE1 · COMPLETED · started Mar 31, 2008ClinicalTrials.gov NCT01444404 · fetched Nov 12, 2026